Hong Chiun Wang

W.T.T. Investment Ltd. is engaged in asset management, stock market and business venture investment. The firm's name was derived from Fubon Group's Chief Executive Officer, Wan-Tsai Tsai (WTT). It joins Series D funding for meat-from-plants maker Beyond Meat. The company is headquartered in Taipei, Taiwan.

Citigroup Private Bank is the private banking subsidiary of Citigroup, Inc. (NYSE: C) in the US. Headquartered in New York City, the firm serves worldly and wealthy individuals and their families with a customized private banking service that crosses borders. They also provide services to professional investors, family offices, and lawyers and law firms.

Convoy Global Holdings Ltd. engages in the provision of financial advisory services. It operates through the following segments: Independent Financial Advisory (IFA), Money Lending, Proprietary Investment, Asset Management, Corporate Finance, and Securities Dealing. The IFA segment includes insurance brokerage business and the provision of independent financial advisory services. The Money Lending segment offers loan financing services. The Proprietary investment segment invests in listed and unlisted investments. The Corporate Finance segment consists of corporate finance and related advisory services. The Securities Dealing segment comprises of securities brokerage, share placing, and margin financing services. The company was founded in 1993 and is headquartered in Hong Kong.

Goldman Sachs (Asia) LLC (GS-Asia) is the Hong Kong-based brokerage subsidiary of Goldman Sachs Holdings (Hong Kong) Ltd., ultimately owned by The Goldman Sachs Group, Inc. (NYSE: GS), a multinational investment bank and financial services company headquartered in New York City. Founded in 1984, GS-Asia provides market insight, risk management and execution services to institutional clients which includes asset managers, hedge funds, banks and brokerages, pensions, endowments and foundations, corporations, and governments.

Fountain Biopharma, Inc. engages in the research, development and sales of antibody drugs. Its products include anti-allergic monoclonal antibody drugs, monoclonal antibody drugs, immune checkpoint aptamer drugs, anti-lag-3 immunological checkpoint aptamer drugs and anti-tumor stem cell labeled antibody drugs. The company was founded on November 25, 2010 and is headquartered in Taipei, Taiwan.